UK News Archive

The UK News Archive contains resources intended for journalists only.

2021

October

Media Release / Oct 28, 2021

Connecting Psoriasis and Psoriatic Arthritis - raising awareness of psoriatic disease

Read More
Media Release / Oct 28, 2021

Novartis Pharmaceuticals UK awarded an Innovation Passport for investigational oral therapy iptacopan (LNP023)

Read More
Media Release / Oct 19, 2021

Novartis awarded Promising Innovative Medicine designation for targeted radioligand theragnostics in prostate cancer

Read More
Media Release / Oct 05, 2021

The first treatment for sickle cell disease in over 20 years, Novartis’ Adakveo®▼ (crizanlizumab) receives NICE recommendation for preventing recurrent vaso-occlusive crises

Read More

September

Media Release / Sep 20, 2021

Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation

Read More
Media Release / Sep 06, 2021

NICE recommends Novartis Cosentyx® (secukinumab) for children and young people with moderate to severe psoriasis

Read More
Media Release / Sep 01, 2021

World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio®▼ (inclisiran) across England

Read More
Media Release / Sep 01, 2021

World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran)

Read More

August

Media Release / Aug 19, 2021

Novartis’ Rydapt ®▼ (midostaurin) is the first and only treatment to receive NICE recommendation for routine funding for patients in England and Wales living with advanced systemic mastocytosis (AdvSM)

Read More

July

Media Release / Jul 26, 2021

Numbers that Matter report from Novartis reveals true burden of immune thrombocytopenia (ITP) and the impact of fatigue on UK patients’ quality of life

Read More

Related Links